Koffee binding affinity is the latest addition to Kvantify's computational drug discovery platform, helping the pharmaceutical and biotech industries design...
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - October 11, 2024) - Cosmo Pharmaceuticals N.V. (SIX:...
Most vulnerable sectors include pharmaceuticals, medical devices, agriculture, defense and aerospace WASHINGTON, Oct. 10, 2024 /PRNewswire/ -- Exiger, the market-leading...
Week Begins with In-Depth Discussions on Life Science Trends and Celebrates Innovative Products that Have Made a Significant Impact on...
BEIJING, Oct. 10, 2024 /PRNewswire/ -- On October 9, 2024, the delegation of international communication experts and foreign media outlets,...
Northvale, New Jersey--(Newsfile Corp. - October 10, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...
The workflow management system market size is projected to reach US$ 60.02 billion by 2031 from US$ 10.23 billion in...
MINNEAPOLIS, Oct. 10, 2024 /PRNewswire/ -- Flywheel.io, the leading end-to-end platform for medical imaging data management and analysis, today announced...
CHICAGO, Oct. 10, 2024 /PRNewswire/ -- EVERSANA, a leading provider of global commercialization services to the life sciences industry, today...
News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA...
Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders Strategic Partnership: Streamlined, single-vendor...
BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today...
SHANGHAI, Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company...
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription...
Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel GoldlustAccess the segment...
SparkCures’ best-in-class clinical trial matching and navigation service is now accessible via myeloma.org.STUDIO CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE)...
DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical...
FDA approval for the IND submission to conduct its trial already secured Vancouver, Canada, Oct. 10, 2024 (GLOBE NEWSWIRE) --...
NEW YORK, Oct. 9, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The Global Automated Industrial Quality Control...